FREE Bionics

FREE Bionics is the leading exoskeleton company, developing medical and industrial exoskeleton devices for human being.

General Information
Company Name
FREE Bionics
Founded Year
2016
Location (Offices)
Japan +2
Founders / Decision Makers
Number of Employees
10
Industries
Biotechnology, Manufacturing
Funding Stage
-
Social Media

FREE Bionics - Company Profile

FREE Bionics is a leading exoskeleton company, founded in 2016, and is dedicated to the development of medical and industrial exoskeleton devices for human use. Their flagship products, FREE Walk and NimBO, cater to the medical sector. Additionally, the company offers contract development and manufacturing organization (CDMO) services for medical and industrial exoskeleton devices. FREE Bionics operates in the Biotechnology and Manufacturing industries, positioning itself at the intersection of cutting-edge technology and healthcare. With a focus on improving the lives of individuals through innovative exoskeleton solutions, FREE Bionics presents an intriguing opportunity for investors in the rapidly evolving field of assistive technologies. While the specific details regarding the last investment and involved investors are not currently available, the company's commitment to enhancing human capabilities through exoskeleton technology makes it an enticing prospect in both the medical and industrial sectors.

Taxonomy: Exoskeleton Technology, Industrial Devices, CDMO Services, Bionics, Rehabilitation Technology

Funding Rounds & Investors of FREE Bionics (0)

View All

There is no investment information

Latest News of FREE Bionics

View All

No recent news or press coverage available for FREE Bionics.

Similar Companies to FREE Bionics

View All
Japet Medical - Similar company to FREE Bionics
Japet Medical Medical technology for health at work.
SkelEx - Similar company to FREE Bionics
SkelEx Crafting custom upper-body exoskeleton solutions to boost productivity and reduce injury risks for aerospace, shipbuilding, and heavy manufacturing workers.